SMS Pharmaceuticals' (NSE:SMSPHARMA) Solid Profits Have Weak Fundamentals - simplywall.st
2025-11-16 • Google News
SMSPHARMA
NSEundefined 368.75-9%
Price Chart
Key Statistics
Market Cap
₹ 0
P/E Ratio
0.00
Revenue (TTM)
₹ 0
Volume
757.88K
52W High
₹ 0.00
52W Low
₹ 0.00
Dividend Yield
0.00%
Beta
0.00
Technicals
50-Day MA
N/A
200-Day MA
N/A
52 Week High
N/A
52 Week Low
N/A
About SMSPHARMA
No description available.
Employees
N/A
Headquarters
N/A
CEO
N/A
Latest News
India's SMS Pharma gains after unit gets US drug regulator approval for Ranitidine - TradingView
2025-11-26 • Google News
SMS Pharma Shares Surge 12% on 74% Profit Jump in Q2FY26 - HDFC Sky
2025-11-10 • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg